Dihydrofolic acid
Dihydrofolic acid | |
---|---|
IUPAC name N-(4-{[(2-amino-4-oxo-1,4,7,8-tetrahydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid | |
Other names H2folate, DH | |
Identifiers | |
CAS number | 4033-27-6 |
PubChem | 98792 |
ChemSpider | 89228 |
MeSH | dihydrofolate |
ChEBI | CHEBI:15633 |
ChEMBL | CHEMBL46294 |
Jmol-3D images | {{#if:O=C(O)[C@@H](NC(=O)c1ccc(cc1)NCC/2=N/C=3C(=O)\N=C(/NC=3NC\2)N)CCC(=O)O|Image 1 |
| |
| |
Properties | |
Molecular formula | C19H21N7O6 |
Molar mass | 443.414 g/mol |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
Infobox references | |
Dihydrofolic acid (dihydrofolate, vitamin B9) is a folic acid derivative which is converted to tetrahydrofolic acid by dihydrofolate reductase. Since tetrahydrofolate is needed to make both purines and pyrimidines, which are building blocks of DNA and RNA, dihydrofolate reductase is targeted by various drugs to prevent nucleic acid synthesis.
Interactive pathway map
Click on genes, proteins and metabolites below to link to respective articles. [§ 1]
- ↑ The interactive pathway map can be edited at WikiPathways: "FluoropyrimidineActivity_WP1601".
References
|
|